ID

DB08957||

名称

Hexoprenaline

描述

Hexoprenaline is a stimulant of beta 2 adrenergic receptors. It is used as a bronchodilator, antiasthmatic, and tocolytic agent.

cas号

3215-70-1

唯一标识码

G9L6B3W684

状态

solid

组

experimental,withdrawn,

指示

药效学

作用机制

毒性

代谢

吸收

半衰期

分类

description:This compound belongs to the class of organic compounds known as catechols. These are compounds containing a 1,2-benzenediol moiety.
direct-parent:Catechols
kingdom:Organic compounds
superclass:Benzenoids
class:Phenols
subclass:Benzenediols
alternative-parent:1,2-aminoalcohols
alternative-parent:1-hydroxy-2-unsubstituted benzenoids
alternative-parent:1-hydroxy-4-unsubstituted benzenoids
alternative-parent:Aralkylamines
alternative-parent:Aromatic alcohols
alternative-parent:Benzene and substituted derivatives
alternative-parent:Dialkylamines
alternative-parent:Hydrocarbon derivatives
alternative-parent:Organopnictogen compounds
alternative-parent:Secondary alcohols
substituent:1,2-aminoalcohol
substituent:1-hydroxy-2-unsubstituted benzenoid
substituent:1-hydroxy-4-unsubstituted benzenoid
substituent:Alcohol
substituent:Amine
substituent:Aralkylamine
substituent:Aromatic alcohol
substituent:Aromatic homomonocyclic compound
substituent:Catechol
substituent:Hydrocarbon derivative
substituent:Monocyclic benzene moiety
substituent:Organic nitrogen compound
substituent:Organic oxygen compound
substituent:Organonitrogen compound
substituent:Organooxygen compound
substituent:Organopnictogen compound
substituent:Secondary alcohol
substituent:Secondary aliphatic amine
substituent:Secondary amine

消除途径

种类

Adrenergic Agents
D018663
Adrenergic Agonists
D000322
Adrenergic beta-2 Receptor Agonists
D058666
Adrenergic beta-Agonists
D000318
Adrenergics for Systemic Use

Adrenergics, Inhalants

Agents producing tachycardia

Agents that produce hypertension

Amines
D000588
Anti-Asthmatic Agents
D018927
Autonomic Agents
D001337
Bronchodilator Agents
D001993
Drugs for Obstructive Airway Diseases

Ethylamines
D005021
Neurotransmitter Agents
D018377
Peripheral Nervous System Agents
D018373
Phenethylamines
D010627
Reproductive Control Agents
D012102
Respiratory System Agents
D019141
Selective Beta 2-adrenergic Agonists

Tocolytic Agents
D015149

盐类

DBSALT001080Hexoprenaline sulfateU851S9102C32266-10-7GTDCHGNGVGRHQY-UHFFFAOYSA-N518.58518.193416477

蛋白质结合

清除

同义词

国际品牌

ArgocianBiolEtoscolDCPCGynipralAlkaloidHexolineShou ChanIpradolNycomedTaicopinDCPC

配送量

产品

混合物

包装者

生产者

价格

受影响的生物体

剂量

form:Injection, solution
route:Intravenous
strength:10 µg/2ml
form:Injection, solution, concentrate
route:Intravenous
strength:25 µg

atc代码

Selective beta-2-adrenoreceptor agonists
ADRENERGICS, INHALANTS
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
RESPIRATORY SYSTEM
Selective beta-2-adrenoreceptor agonists
ADRENERGICS FOR SYSTEMIC USE
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
RESPIRATORY SYSTEM

fda标签

化学品安全技术说明书

专利

食物相互作用

药物相互作用

DB00177
Hexoprenaline may decrease the antihypertensive activities of Valsartan.
DB00178
Hexoprenaline may decrease the antihypertensive activities of Ramipril.
DB00206
Hexoprenaline may decrease the antihypertensive activities of Reserpine.
DB00212
Hexoprenaline may decrease the antihypertensive activities of Remikiren.
DB00270
Hexoprenaline may decrease the antihypertensive activities of Isradipine.
DB00275
Hexoprenaline may decrease the antihypertensive activities of Olmesartan.
DB00325
Hexoprenaline may decrease the antihypertensive activities of Nitroprusside.
DB00343
Hexoprenaline may decrease the antihypertensive activities of Diltiazem.
DB00350
Hexoprenaline may decrease the antihypertensive activities of Minoxidil.
DB00374
Hexoprenaline may decrease the antihypertensive activities of Treprostinil.
DB00381
Hexoprenaline may decrease the antihypertensive activities of Amlodipine.
DB00393
Hexoprenaline may decrease the antihypertensive activities of Nimodipine.
DB00401
Hexoprenaline may decrease the antihypertensive activities of Nisoldipine.
DB00492
Hexoprenaline may decrease the antihypertensive activities of Fosinopril.
DB00519
Hexoprenaline may decrease the antihypertensive activities of Trandolapril.
DB00528
Hexoprenaline may decrease the antihypertensive activities of Lercanidipine.
DB00542
Hexoprenaline may decrease the antihypertensive activities of Benazepril.
DB00559
Hexoprenaline may decrease the antihypertensive activities of Bosentan.
DB00584
Hexoprenaline may decrease the antihypertensive activities of Enalapril.
DB00606
Hexoprenaline may decrease the antihypertensive activities of Cyclothiazide.
DB00616
Hexoprenaline may decrease the antihypertensive activities of Candoxatril.
DB00657
Hexoprenaline may decrease the antihypertensive activities of Mecamylamine.
DB00678
Hexoprenaline may decrease the antihypertensive activities of Losartan.
DB00691
Hexoprenaline may decrease the antihypertensive activities of Moexipril.
DB00700
Hexoprenaline may decrease the antihypertensive activities of Eplerenone.
DB00722
Hexoprenaline may decrease the antihypertensive activities of Lisinopril.
DB00727
Hexoprenaline may decrease the antihypertensive activities of Nitroglycerin.
DB00765
Hexoprenaline may decrease the antihypertensive activities of Metyrosine.
DB00785
Hexoprenaline may decrease the antihypertensive activities of Cryptenamine.
DB00790
Hexoprenaline may decrease the antihypertensive activities of Perindopril.
DB00796
Hexoprenaline may decrease the antihypertensive activities of Candesartan cilexetil.
DB00800
Hexoprenaline may decrease the antihypertensive activities of Fenoldopam.
DB00820
Hexoprenaline may decrease the antihypertensive activities of Tadalafil.
DB00876
Hexoprenaline may decrease the antihypertensive activities of Eprosartan.
DB00881
Hexoprenaline may decrease the antihypertensive activities of Quinapril.
DB00966
Hexoprenaline may decrease the antihypertensive activities of Telmisartan.
DB00968
Hexoprenaline may decrease the antihypertensive activities of Methyldopa.
DB01029
Hexoprenaline may decrease the antihypertensive activities of Irbesartan.
DB01054
Hexoprenaline may decrease the antihypertensive activities of Nitrendipine.
DB01089
Hexoprenaline may decrease the antihypertensive activities of Deserpidine.
DB01090
Hexoprenaline may decrease the antihypertensive activities of Pentolinium.
DB01116
Hexoprenaline may decrease the antihypertensive activities of Trimethaphan.
DB01119
Hexoprenaline may decrease the antihypertensive activities of Diazoxide.
DB01197
Hexoprenaline may decrease the antihypertensive activities of Captopril.
DB01240
Hexoprenaline may decrease the antihypertensive activities of Epoprostenol.
DB01244
Hexoprenaline may decrease the antihypertensive activities of Bepridil.
DB01275
Hexoprenaline may decrease the antihypertensive activities of Hydralazine.
DB01340
Hexoprenaline may decrease the antihypertensive activities of Cilazapril.
DB01347
Hexoprenaline may decrease the antihypertensive activities of Saprisartan.
DB01348
Hexoprenaline may decrease the antihypertensive activities of Spirapril.
DB01388
Hexoprenaline may decrease the antihypertensive activities of Mibefradil.
DB04831
Hexoprenaline may decrease the antihypertensive activities of Tienilic acid.
DB04840
Hexoprenaline may decrease the antihypertensive activities of Debrisoquine.
DB06268
Hexoprenaline may decrease the antihypertensive activities of Sitaxentan.
DB06403
Hexoprenaline may decrease the antihypertensive activities of Ambrisentan.
DB06445
Hexoprenaline may decrease the antihypertensive activities of Diethylnorspermine.
DB06712
Hexoprenaline may decrease the antihypertensive activities of Nilvadipine.
DB06762
Hexoprenaline may decrease the antihypertensive activities of Pinacidil.
DB07767
Hexoprenaline may decrease the antihypertensive activities of Ferulic acid.
DB08836
Hexoprenaline may decrease the antihypertensive activities of Temocapril.
DB08931
Hexoprenaline may decrease the antihypertensive activities of Riociguat.
DB08932
Hexoprenaline may decrease the antihypertensive activities of Macitentan.
DB08960
Hexoprenaline may decrease the antihypertensive activities of Hexamethonium.
DB09026
Hexoprenaline may decrease the antihypertensive activities of Aliskiren.
DB09220
Hexoprenaline may decrease the antihypertensive activities of Nicorandil.
DB09235
Hexoprenaline may decrease the antihypertensive activities of Efonidipine.
DB09236
Hexoprenaline may decrease the antihypertensive activities of Lacidipine.
DB09238
Hexoprenaline may decrease the antihypertensive activities of Manidipine.
DB09363
Hexoprenaline may decrease the antihypertensive activities of Rauwolfia serpentina root.
DB09477
Hexoprenaline may decrease the antihypertensive activities of Enalaprilat.
DB11362
Hexoprenaline may decrease the antihypertensive activities of Selexipag.
DB11720
Hexoprenaline may decrease the antihypertensive activities of Angiotensin 1-7.
DB11783
Hexoprenaline may decrease the antihypertensive activities of Imidapril.
DB12054
Hexoprenaline may decrease the antihypertensive activities of BQ-123.
DB12093
Hexoprenaline may decrease the antihypertensive activities of Tetrahydropalmatine.
DB12465
Hexoprenaline may decrease the antihypertensive activities of Ketanserin.
DB12766
Hexoprenaline may decrease the antihypertensive activities of Cicletanine.
DB12945
Hexoprenaline may decrease the antihypertensive activities of Dihydralazine.
DB13166
Hexoprenaline may decrease the antihypertensive activities of Zofenopril.
DB13211
Hexoprenaline may decrease the antihypertensive activities of Guanoxan.
DB13312
Hexoprenaline may decrease the antihypertensive activities of Delapril.
DB13374
Hexoprenaline may decrease the antihypertensive activities of Vincamine.
DB13400
Hexoprenaline may decrease the antihypertensive activities of Linsidomine.
DB13410
Hexoprenaline may decrease the antihypertensive activities of Guanoxabenz.
DB13429
Hexoprenaline may decrease the antihypertensive activities of Tolonidine.
DB13435
Hexoprenaline may decrease the antihypertensive activities of Endralazine.
DB13452
Hexoprenaline may decrease the antihypertensive activities of Cadralazine.
DB13575
Hexoprenaline may decrease the antihypertensive activities of Bietaserpine.
DB13604
Hexoprenaline may decrease the antihypertensive activities of Guanazodine.
DB13631
Hexoprenaline may decrease the antihypertensive activities of Methoserpidine.
DB13779
Hexoprenaline may decrease the antihypertensive activities of Guanoclor.
DB13801
Hexoprenaline may decrease the antihypertensive activities of Muzolimine.
DB13803
Hexoprenaline may decrease the antihypertensive activities of Xipamide.
DB13919
Hexoprenaline may decrease the antihypertensive activities of Candesartan.
DB14068
Hexoprenaline may decrease the antihypertensive activities of Dexniguldipine.
DB14094
Hexoprenaline may decrease the antihypertensive activities of Tocopherylquinone.
DB14125
Hexoprenaline may decrease the antihypertensive activities of Benazeprilat.
DB14207
Hexoprenaline may decrease the antihypertensive activities of Fosinoprilat.
DB14208
Hexoprenaline may decrease the antihypertensive activities of Ramiprilat.
DB14213
Hexoprenaline may decrease the antihypertensive activities of Perindoprilat.
DB14217
Hexoprenaline may decrease the antihypertensive activities of Quinaprilat.
DB01023
Felodipine may decrease the antihypertensive activities of Hexoprenaline.
DB09237
Hexoprenaline may decrease the antihypertensive activities of Levamlodipine.
DB00035
The risk or severity of hypertension can be increased when Desmopressin is combined with Hexoprenaline.
DB00091
The risk or severity of hypertension can be increased when Cyclosporine is combined with Hexoprenaline.
DB00159
The risk or severity of hypertension can be increased when Icosapent is combined with Hexoprenaline.
DB00182
The risk or severity of hypertension can be increased when Amphetamine is combined with Hexoprenaline.
DB00191
The risk or severity of hypertension can be increased when Phentermine is combined with Hexoprenaline.
DB00211
The risk or severity of hypertension can be increased when Midodrine is combined with Hexoprenaline.
DB00216
The risk or severity of hypertension can be increased when Eletriptan is combined with Hexoprenaline.
DB00217
The risk or severity of hypertension can be increased when Bethanidine is combined with Hexoprenaline.
DB00244
The risk or severity of hypertension can be increased when Mesalazine is combined with Hexoprenaline.
DB00292
The risk or severity of hypertension can be increased when Etomidate is combined with Hexoprenaline.
DB00315
The risk or severity of hypertension can be increased when Zolmitriptan is combined with Hexoprenaline.
DB00328
The risk or severity of hypertension can be increased when Indomethacin is combined with Hexoprenaline.
DB00370
The risk or severity of hypertension can be increased when Mirtazapine is combined with Hexoprenaline.
DB00388
The risk or severity of hypertension can be increased when Phenylephrine is combined with Hexoprenaline.
DB00422
The risk or severity of hypertension can be increased when Methylphenidate is combined with Hexoprenaline.
DB00461
The risk or severity of hypertension can be increased when Nabumetone is combined with Hexoprenaline.
DB00465
The risk or severity of hypertension can be increased when Ketorolac is combined with Hexoprenaline.
DB00469
The risk or severity of hypertension can be increased when Tenoxicam is combined with Hexoprenaline.
DB00482
The risk or severity of hypertension can be increased when Celecoxib is combined with Hexoprenaline.
DB00490
The risk or severity of hypertension can be increased when Buspirone is combined with Hexoprenaline.
DB00500
The risk or severity of hypertension can be increased when Tolmetin is combined with Hexoprenaline.
DB00533
The risk or severity of hypertension can be increased when Rofecoxib is combined with Hexoprenaline.
DB00554
The risk or severity of hypertension can be increased when Piroxicam is combined with Hexoprenaline.
DB00561
The risk or severity of hypertension can be increased when Doxapram is combined with Hexoprenaline.
DB00572
The risk or severity of hypertension can be increased when Atropine is combined with Hexoprenaline.
DB00573
The risk or severity of hypertension can be increased when Fenoprofen is combined with Hexoprenaline.
DB00575
The risk or severity of hypertension can be increased when Clonidine is combined with Hexoprenaline.
DB00580
The risk or severity of hypertension can be increased when Valdecoxib is combined with Hexoprenaline.
DB00586
The risk or severity of hypertension can be increased when Diclofenac is combined with Hexoprenaline.
DB00605
The risk or severity of hypertension can be increased when Sulindac is combined with Hexoprenaline.
DB00610
The risk or severity of hypertension can be increased when Metaraminol is combined with Hexoprenaline.
DB00629
The risk or severity of hypertension can be increased when Guanabenz is combined with Hexoprenaline.
DB00633
The risk or severity of hypertension can be increased when Dexmedetomidine is combined with Hexoprenaline.
DB00669
The risk or severity of hypertension can be increased when Sumatriptan is combined with Hexoprenaline.
DB00708
The risk or severity of hypertension can be increased when Sufentanil is combined with Hexoprenaline.
DB00712
The risk or severity of hypertension can be increased when Flurbiprofen is combined with Hexoprenaline.
DB00723
The risk or severity of hypertension can be increased when Methoxamine is combined with Hexoprenaline.
DB00749
The risk or severity of hypertension can be increased when Etodolac is combined with Hexoprenaline.
DB00753
The risk or severity of hypertension can be increased when Isoflurane is combined with Hexoprenaline.
DB00784
The risk or severity of hypertension can be increased when Mefenamic acid is combined with Hexoprenaline.
DB00788
The risk or severity of hypertension can be increased when Naproxen is combined with Hexoprenaline.
DB00795
The risk or severity of hypertension can be increased when Sulfasalazine is combined with Hexoprenaline.
DB00802
The risk or severity of hypertension can be increased when Alfentanil is combined with Hexoprenaline.
DB00812
The risk or severity of hypertension can be increased when Phenylbutazone is combined with Hexoprenaline.
DB00813
The risk or severity of hypertension can be increased when Fentanyl is combined with Hexoprenaline.
DB00814
The risk or severity of hypertension can be increased when Meloxicam is combined with Hexoprenaline.
DB00818
The risk or severity of hypertension can be increased when Propofol is combined with Hexoprenaline.
DB00821
The risk or severity of hypertension can be increased when Carprofen is combined with Hexoprenaline.
DB00830
The risk or severity of hypertension can be increased when Phenmetrazine is combined with Hexoprenaline.
DB00852
The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Hexoprenaline.
DB00861
The risk or severity of hypertension can be increased when Diflunisal is combined with Hexoprenaline.
DB00865
The risk or severity of hypertension can be increased when Benzphetamine is combined with Hexoprenaline.
DB00886
The risk or severity of hypertension can be increased when Omapatrilat is combined with Hexoprenaline.
DB00899
The risk or severity of hypertension can be increased when Remifentanil is combined with Hexoprenaline.
DB00918
The risk or severity of hypertension can be increased when Almotriptan is combined with Hexoprenaline.
DB00935
The risk or severity of hypertension can be increased when Oxymetazoline is combined with Hexoprenaline.
DB00936
The risk or severity of hypertension can be increased when Salicylic acid is combined with Hexoprenaline.
DB00937
The risk or severity of hypertension can be increased when Diethylpropion is combined with Hexoprenaline.
DB00939
The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Hexoprenaline.
DB00945
The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Hexoprenaline.
DB00952
The risk or severity of hypertension can be increased when Naratriptan is combined with Hexoprenaline.
DB00953
The risk or severity of hypertension can be increased when Rizatriptan is combined with Hexoprenaline.
DB00988
The risk or severity of hypertension can be increased when Dopamine is combined with Hexoprenaline.
DB00991
The risk or severity of hypertension can be increased when Oxaprozin is combined with Hexoprenaline.
DB00998
The risk or severity of hypertension can be increased when Frovatriptan is combined with Hexoprenaline.
DB01009
The risk or severity of hypertension can be increased when Ketoprofen is combined with Hexoprenaline.
DB01014
The risk or severity of hypertension can be increased when Balsalazide is combined with Hexoprenaline.
DB01018
The risk or severity of hypertension can be increased when Guanfacine is combined with Hexoprenaline.
DB01028
The risk or severity of hypertension can be increased when Methoxyflurane is combined with Hexoprenaline.
DB01050
The risk or severity of hypertension can be increased when Ibuprofen is combined with Hexoprenaline.
DB01126
The risk or severity of hypertension can be increased when Dutasteride is combined with Hexoprenaline.
DB01159
The risk or severity of hypertension can be increased when Halothane is combined with Hexoprenaline.
DB01180
The risk or severity of hypertension can be increased when Rescinnamine is combined with Hexoprenaline.
DB01189
The risk or severity of hypertension can be increased when Desflurane is combined with Hexoprenaline.
DB01216
The risk or severity of hypertension can be increased when Finasteride is combined with Hexoprenaline.
DB01236
The risk or severity of hypertension can be increased when Sevoflurane is combined with Hexoprenaline.
DB01250
The risk or severity of hypertension can be increased when Olsalazine is combined with Hexoprenaline.
DB01255
The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Hexoprenaline.
DB01283
The risk or severity of hypertension can be increased when Lumiracoxib is combined with Hexoprenaline.
DB01364
The risk or severity of hypertension can be increased when Ephedrine is combined with Hexoprenaline.
DB01365
The risk or severity of hypertension can be increased when Mephentermine is combined with Hexoprenaline.
DB01392
The risk or severity of hypertension can be increased when Yohimbine is combined with Hexoprenaline.
DB01397
The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Hexoprenaline.
DB01399
The risk or severity of hypertension can be increased when Salsalate is combined with Hexoprenaline.
DB01401
The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Hexoprenaline.
DB01419
The risk or severity of hypertension can be increased when Antrafenine is combined with Hexoprenaline.
DB01424
The risk or severity of hypertension can be increased when Aminophenazone is combined with Hexoprenaline.
DB01435
The risk or severity of hypertension can be increased when Antipyrine is combined with Hexoprenaline.
DB01442
The risk or severity of hypertension can be increased when MMDA is combined with Hexoprenaline.
DB01454
The risk or severity of hypertension can be increased when Midomafetamine is combined with Hexoprenaline.
DB01467
The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Hexoprenaline.
DB01472
The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Hexoprenaline.
DB01484
The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Hexoprenaline.
DB01509
The risk or severity of hypertension can be increased when Tenamfetamine is combined with Hexoprenaline.
DB01556
The risk or severity of hypertension can be increased when Chlorphentermine is combined with Hexoprenaline.
DB01576
The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Hexoprenaline.
DB01577
The risk or severity of hypertension can be increased when Metamfetamine is combined with Hexoprenaline.
DB01579
The risk or severity of hypertension can be increased when Phendimetrazine is combined with Hexoprenaline.
DB01591
The risk or severity of hypertension can be increased when Solifenacin is combined with Hexoprenaline.
DB01600
The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Hexoprenaline.
DB01628
The risk or severity of hypertension can be increased when Etoricoxib is combined with Hexoprenaline.
DB02032
The risk or severity of hypertension can be increased when Epicaptopril is combined with Hexoprenaline.
DB02224
The risk or severity of hypertension can be increased when Taxifolin is combined with Hexoprenaline.
DB03585
The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Hexoprenaline.
DB04581
The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Hexoprenaline.
DB04743
The risk or severity of hypertension can be increased when Nimesulide is combined with Hexoprenaline.
DB04812
The risk or severity of hypertension can be increased when Benoxaprofen is combined with Hexoprenaline.
DB04817
The risk or severity of hypertension can be increased when Metamizole is combined with Hexoprenaline.
DB04828
The risk or severity of hypertension can be increased when Zomepirac is combined with Hexoprenaline.
DB04908
The risk or severity of hypertension can be increased when Flibanserin is combined with Hexoprenaline.
DB04948
The risk or severity of hypertension can be increased when Lofexidine is combined with Hexoprenaline.
DB05095
The risk or severity of hypertension can be increased when Cimicoxib is combined with Hexoprenaline.
DB05271
The risk or severity of hypertension can be increased when Rotigotine is combined with Hexoprenaline.
DB05395
The risk or severity of hypertension can be increased when Amibegron is combined with Hexoprenaline.
DB05562
The risk or severity of hypertension can be increased when Naluzotan is combined with Hexoprenaline.
DB06016
The risk or severity of hypertension can be increased when Cariprazine is combined with Hexoprenaline.
DB06148
The risk or severity of hypertension can be increased when Mianserin is combined with Hexoprenaline.
DB06152
The risk or severity of hypertension can be increased when Nylidrin is combined with Hexoprenaline.
DB06190
The risk or severity of hypertension can be increased when Solabegron is combined with Hexoprenaline.
DB06678
The risk or severity of hypertension can be increased when Esmirtazapine is combined with Hexoprenaline.
DB06684
The risk or severity of hypertension can be increased when Vilazodone is combined with Hexoprenaline.
DB06690
The risk or severity of hypertension can be increased when Nitrous oxide is combined with Hexoprenaline.
DB06694
The risk or severity of hypertension can be increased when Xylometazoline is combined with Hexoprenaline.
DB06701
The risk or severity of hypertension can be increased when Dexmethylphenidate is combined with Hexoprenaline.
DB06706
The risk or severity of hypertension can be increased when Isometheptene is combined with Hexoprenaline.
DB06707
The risk or severity of hypertension can be increased when Levonordefrin is combined with Hexoprenaline.
DB06711
The risk or severity of hypertension can be increased when Naphazoline is combined with Hexoprenaline.
DB06725
The risk or severity of hypertension can be increased when Lornoxicam is combined with Hexoprenaline.
DB06736
The risk or severity of hypertension can be increased when Aceclofenac is combined with Hexoprenaline.
DB06737
The risk or severity of hypertension can be increased when Zaltoprofen is combined with Hexoprenaline.
DB06763
The risk or severity of hypertension can be increased when Saralasin is combined with Hexoprenaline.
DB06764
The risk or severity of hypertension can be increased when Tetryzoline is combined with Hexoprenaline.
DB07402
The risk or severity of hypertension can be increased when Azapropazone is combined with Hexoprenaline.
DB08439
The risk or severity of hypertension can be increased when Parecoxib is combined with Hexoprenaline.
DB08797
The risk or severity of hypertension can be increased when Salicylamide is combined with Hexoprenaline.
DB08810
The risk or severity of hypertension can be increased when Cinitapride is combined with Hexoprenaline.
DB08815
The risk or severity of hypertension can be increased when Lurasidone is combined with Hexoprenaline.
DB08841
The risk or severity of hypertension can be increased when Tyramine is combined with Hexoprenaline.
DB08893
The risk or severity of hypertension can be increased when Mirabegron is combined with Hexoprenaline.
DB08925
The risk or severity of hypertension can be increased when Adrafinil is combined with Hexoprenaline.
DB08940
The risk or severity of hypertension can be increased when Kebuzone is combined with Hexoprenaline.
DB08941
The risk or severity of hypertension can be increased when Isoxsuprine is combined with Hexoprenaline.
DB08942
The risk or severity of hypertension can be increased when Isoxicam is combined with Hexoprenaline.
DB08951
The risk or severity of hypertension can be increased when Indoprofen is combined with Hexoprenaline.
DB08954
The risk or severity of hypertension can be increased when Ifenprodil is combined with Hexoprenaline.
DB08955
The risk or severity of hypertension can be increased when Ibuproxam is combined with Hexoprenaline.
DB08976
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Floctafenine.
DB08981
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Fenbufen.
DB08984
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Etofenamate.
DB08985
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Etilefrine.
DB08991
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Epirizole.
DB09061
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Cannabidiol.
DB09068
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Vortioxetine.
DB09084
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Benzydamine.
DB09202
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Cirazoline.
DB09203
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Synephrine.
DB09205
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Moxisylyte.
DB09213
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Dexibuprofen.
DB09214
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Dexketoprofen.
DB09215
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Droxicam.
DB09216
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Tolfenamic acid.
DB09217
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Firocoxib.
DB09218
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Clonixin.
DB09242
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Moxonidine.
DB09285
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Morniflumate.
DB09288
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Propacetamol.
DB09295
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Talniflumate.
DB09480
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Iofetamine I-123.
DB11278
The risk or severity of hypertension can be increased when Hexoprenaline is combined with DL-Methylephedrine.
DB11373
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Amitraz.
DB11428
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Medetomidine.
DB11455
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Robenacoxib.
DB11466
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Tepoxalin.
DB11477
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Xylazine.
DB11481
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Atipamezole.
DB11518
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Flunixin.
DB11541
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Ractopamine.
DB11543
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Romifidine.
DB11556
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Detomidine.
DB11738
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Rilmenidine.
DB11755
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Tetrahydrocannabivarin.
DB12080
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Ritobegron.
DB12092
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Naftopidil.
DB12248
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Tulobuterol.
DB12313
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Dopexamine.
DB12361
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Piclozotan.
DB12371
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Siponimod.
DB12445
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Nitroaspirin.
DB12545
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Indobufen.
DB12551
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Idazoxan.
DB12610
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Ebselen.
DB12779
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Higenamine.
DB12846
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Reproterol.
DB12927
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Theodrenaline.
DB13001
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Tinoridine.
DB13064
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Tramazoline.
DB13108
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Mephedrone.
DB13167
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Alclofenac.
DB13217
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Fentiazac.
DB13232
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Suxibuzone.
DB13251
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Octopamine.
DB13286
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Bumadizone.
DB13314
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Alminoprofen.
DB13323
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Trichloroethylene.
DB13341
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Fenozolone.
DB13371
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Difenpiramide.
DB13378
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Norfenefrine.
DB13398
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Oxyfedrine.
DB13407
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Nifenazone.
DB13432
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Lonazolac.
DB13453
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Xenon.
DB13481
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Tenidap.
DB13510
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Buflomedil.
DB13524
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Propyphenazone.
DB13527
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Proglumetacin.
DB13538
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Guacetisal.
DB13544
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Ethenzamide.
DB13559
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Rimiterol.
DB13598
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Diethyl ether.
DB13612
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Carbaspirin calcium.
DB13624
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Methoxyphenamine.
DB13629
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Mofebutazone.
DB13649
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Proquazone.
DB13657
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Benorilate.
DB13692
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Tretoquinol.
DB13703
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Gepefrine.
DB13722
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Pirprofen.
DB13777
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Prenalterol.
DB13781
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Xamoterol.
DB13783
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Acemetacin.
DB13852
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Mefenorex.
DB13860
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Imidazole salicylate.
DB13917
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Deoxyepinephrine.
DB13940
The risk or severity of hypertension can be increased when Hexoprenaline is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
DB14010
The risk or severity of hypertension can be increased when Hexoprenaline is combined with 5-methoxy-N,N-dimethyltryptamine.
DB14059
The risk or severity of hypertension can be increased when Hexoprenaline is combined with SC-236.
DB14060
The risk or severity of hypertension can be increased when Hexoprenaline is combined with NS-398.
DB14231
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Quinoline Yellow WS.
DB15685
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Selpercatinib.
DB09212
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Loxoprofen.
DB15965
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Naxitamab.
DB00895
Hexoprenaline may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.
DB00421
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Spironolactone.
DB00180
The risk or severity of hypokalemia can be increased when Flunisolide is combined with Hexoprenaline.
DB00394
The risk or severity of hypokalemia can be increased when Beclomethasone dipropionate is combined with Hexoprenaline.
DB00443
The risk or severity of hypokalemia can be increased when Betamethasone is combined with Hexoprenaline.
DB00588
The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Hexoprenaline.
DB00591
The risk or severity of hypokalemia can be increased when Fluocinolone acetonide is combined with Hexoprenaline.
DB00620
The risk or severity of hypokalemia can be increased when Triamcinolone is combined with Hexoprenaline.
DB00635
The risk or severity of hypokalemia can be increased when Prednisone is combined with Hexoprenaline.
DB00687
The risk or severity of hypokalemia can be increased when Fludrocortisone is combined with Hexoprenaline.
DB00741
The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Hexoprenaline.
DB00860
The risk or severity of hypokalemia can be increased when Prednisolone is combined with Hexoprenaline.
DB00959
The risk or severity of hypokalemia can be increased when Methylprednisolone is combined with Hexoprenaline.
DB01108
The risk or severity of hypokalemia can be increased when Trilostane is combined with Hexoprenaline.
DB01222
The risk or severity of hypokalemia can be increased when Budesonide is combined with Hexoprenaline.
DB01234
The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Hexoprenaline.
DB01285
The risk or severity of hypokalemia can be increased when Corticotropin is combined with Hexoprenaline.
DB01380
The risk or severity of hypokalemia can be increased when Cortisone acetate is combined with Hexoprenaline.
DB01384
The risk or severity of hypokalemia can be increased when Paramethasone is combined with Hexoprenaline.
DB01410
The risk or severity of hypokalemia can be increased when Ciclesonide is combined with Hexoprenaline.
DB04630
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Hexoprenaline.
DB08906
The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Hexoprenaline.
DB08970
The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Hexoprenaline.
DB09091
The risk or severity of hypokalemia can be increased when Tixocortol is combined with Hexoprenaline.
DB09378
The risk or severity of hypokalemia can be increased when Fluprednisolone is combined with Hexoprenaline.
DB09383
The risk or severity of hypokalemia can be increased when Meprednisone is combined with Hexoprenaline.
DB11487
The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Hexoprenaline.
DB11529
The risk or severity of hypokalemia can be increased when Melengestrol is combined with Hexoprenaline.
DB11921
The risk or severity of hypokalemia can be increased when Deflazacort is combined with Hexoprenaline.
DB13003
The risk or severity of hypokalemia can be increased when Cortivazol is combined with Hexoprenaline.
DB13208
The risk or severity of hypokalemia can be increased when Prednylidene is combined with Hexoprenaline.
DB13223
The risk or severity of hypokalemia can be increased when Fluocortin is combined with Hexoprenaline.
DB13491
The risk or severity of hypokalemia can be increased when Fluperolone is combined with Hexoprenaline.
DB13843
The risk or severity of hypokalemia can be increased when Cloprednol is combined with Hexoprenaline.
DB13856
The risk or severity of hypokalemia can be increased when Fluclorolone is combined with Hexoprenaline.
DB13867
The risk or severity of hypokalemia can be increased when Fluticasone is combined with Hexoprenaline.
DB14512
The risk or severity of hypokalemia can be increased when Mometasone furoate is combined with Hexoprenaline.
DB14539
The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Hexoprenaline.
DB14541
The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Hexoprenaline.
DB14545
The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Hexoprenaline.
DB14631
The risk or severity of hypokalemia can be increased when Prednisolone phosphate is combined with Hexoprenaline.
DB14633
The risk or severity of hypokalemia can be increased when Prednisolone hemisuccinate is combined with Hexoprenaline.
DB14644
The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Hexoprenaline.
DB14646
The risk or severity of hypokalemia can be increased when Prednisone acetate is combined with Hexoprenaline.
DB14652
The risk or severity of hypokalemia can be increased when Clocortolone acetate is combined with Hexoprenaline.
DB14659
The risk or severity of hypokalemia can be increased when Melengestrol acetate is combined with Hexoprenaline.
DB14669
The risk or severity of hypokalemia can be increased when Betamethasone phosphate is combined with Hexoprenaline.
DB14681
The risk or severity of hypokalemia can be increased when Cortisone is combined with Hexoprenaline.
DB01013
The risk or severity of hypokalemia can be increased when Clobetasol propionate is combined with Hexoprenaline.
DB01047
The risk or severity of hypokalemia can be increased when Fluocinonide is combined with Hexoprenaline.
DB14540
The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Hexoprenaline.
DB00547
The risk or severity of hypokalemia can be increased when Desoximetasone is combined with Hexoprenaline.
DB00764
The risk or severity of hypokalemia can be increased when Mometasone is combined with Hexoprenaline.
DB08971
The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Hexoprenaline.
DB11750
The risk or severity of hypokalemia can be increased when Clobetasol is combined with Hexoprenaline.
DB15566
The risk or severity of hypokalemia can be increased when Prednisolone acetate is combined with Hexoprenaline.
DB00324
The risk or severity of hypokalemia can be increased when Fluorometholone is combined with Hexoprenaline.
DB09095
The risk or severity of hypokalemia can be increased when Difluocortolone is combined with Hexoprenaline.
DB00289
Atomoxetine may increase the tachycardic activities of Hexoprenaline.
DB09059
The risk or severity of adverse effects can be increased when Hexoprenaline is combined with Atosiban.
DB06698
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Betahistine.
DB00247
Methysergide may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB00248
Cabergoline may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB00320
Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB00353
Methylergometrine may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB00589
Lisuride may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB00696
Ergotamine may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB00699
Nicergoline may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB01049
Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB01186
Pergolide may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB01200
Bromocriptine may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB01253
Ergometrine may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB04829
Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB11273
Dihydroergocornine may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB13345
Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB13385
Dihydroergocryptine may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB13399
Terguride may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB13520
Metergoline may increase the hypertensive and vasoconstricting activities of Hexoprenaline.
DB00285
Venlafaxine may increase the tachycardic activities of Hexoprenaline.
DB00476
Duloxetine may increase the tachycardic activities of Hexoprenaline.
DB01105
Sibutramine may increase the tachycardic activities of Hexoprenaline.
DB04896
Milnacipran may increase the tachycardic activities of Hexoprenaline.
DB06700
Desvenlafaxine may increase the tachycardic activities of Hexoprenaline.
DB08918
Levomilnacipran may increase the tachycardic activities of Hexoprenaline.
DB00246
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Ziprasidone.
DB00334
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Olanzapine.
DB00346
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Alfuzosin.
DB00363
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Clozapine.
DB00420
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Promazine.
DB00450
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Droperidol.
DB00457
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Prazosin.
DB00477
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Chlorpromazine.
DB00590
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Doxazosin.
DB00622
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Nicardipine.
DB00656
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Trazodone.
DB00661
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Verapamil.
DB00679
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Thioridazine.
DB00692
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Phentolamine.
DB00706
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Tamsulosin.
DB00734
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Risperidone.
DB00777
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Propiomazine.
DB00797
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Tolazoline.
DB00831
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Trifluoperazine.
DB00875
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Flupentixol.
DB00908
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Quinidine.
DB00925
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Phenoxybenzamine.
DB01149
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Nefazodone.
DB01162
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Terazosin.
DB01224
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Quetiapine.
DB01238
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Aripiprazole.
DB01267
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Paliperidone.
DB01403
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Methotrimeprazine.
DB01608
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Periciazine.
DB01614
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Acepromazine.
DB01622
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Thioproperazine.
DB01624
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Zuclopenthixol.
DB04855
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Dronedarone.
DB04946
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Iloperidone.
DB06153
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Pizotifen.
DB06207
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Silodosin.
DB06216
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Asenapine.
DB08950
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Indoramin.
DB09128
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Brexpiprazole.
DB09206
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Trimazosin.
DB09239
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Niguldipine.
DB12230
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Bunazosin.
DB12278
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Propiverine.
DB12661
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Urapidil.
DB14185
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Aripiprazole lauroxil.
DB00321
The risk or severity of hypertension can be increased when Amitriptyline is combined with Hexoprenaline.
DB00344
The risk or severity of hypertension can be increased when Protriptyline is combined with Hexoprenaline.
DB00458
The risk or severity of hypertension can be increased when Imipramine is combined with Hexoprenaline.
DB00540
The risk or severity of hypertension can be increased when Nortriptyline is combined with Hexoprenaline.
DB00543
The risk or severity of hypertension can be increased when Amoxapine is combined with Hexoprenaline.
DB00726
The risk or severity of hypertension can be increased when Trimipramine is combined with Hexoprenaline.
DB01142
The risk or severity of hypertension can be increased when Doxepin is combined with Hexoprenaline.
DB01151
The risk or severity of hypertension can be increased when Desipramine is combined with Hexoprenaline.
DB01242
The risk or severity of hypertension can be increased when Clomipramine is combined with Hexoprenaline.
DB04836
The risk or severity of hypertension can be increased when Amineptine is combined with Hexoprenaline.
DB08996
The risk or severity of hypertension can be increased when Dimetacrine is combined with Hexoprenaline.
DB09016
The risk or severity of hypertension can be increased when Butriptyline is combined with Hexoprenaline.
DB09167
The risk or severity of hypertension can be increased when Dosulepin is combined with Hexoprenaline.
DB09289
The risk or severity of hypertension can be increased when Tianeptine is combined with Hexoprenaline.
DB09307
The risk or severity of hypertension can be increased when Oxaprotiline is combined with Hexoprenaline.
DB12930
The risk or severity of hypertension can be increased when Opipramol is combined with Hexoprenaline.
DB13114
The risk or severity of hypertension can be increased when Amitriptylinoxide is combined with Hexoprenaline.
DB13225
The risk or severity of hypertension can be increased when Dibenzepin is combined with Hexoprenaline.
DB13246
The risk or severity of hypertension can be increased when Quinupramine is combined with Hexoprenaline.
DB13384
The risk or severity of hypertension can be increased when Melitracen is combined with Hexoprenaline.
DB13411
The risk or severity of hypertension can be increased when Lofepramine is combined with Hexoprenaline.
DB13496
The risk or severity of hypertension can be increased when Iprindole is combined with Hexoprenaline.
DB13782
The risk or severity of hypertension can be increased when Imipramine oxide is combined with Hexoprenaline.
DB00373
Timolol may decrease the bronchodilatory activities of Hexoprenaline.
DB00489
Sotalol may decrease the bronchodilatory activities of Hexoprenaline.
DB00571
Propranolol may decrease the bronchodilatory activities of Hexoprenaline.
DB00866
Alprenolol may decrease the bronchodilatory activities of Hexoprenaline.
DB00960
Pindolol may decrease the bronchodilatory activities of Hexoprenaline.
DB01203
Nadolol may decrease the bronchodilatory activities of Hexoprenaline.
DB01359
Penbutolol may decrease the bronchodilatory activities of Hexoprenaline.
DB01580
Oxprenolol may decrease the bronchodilatory activities of Hexoprenaline.
DB08807
Bopindolol may decrease the bronchodilatory activities of Hexoprenaline.
DB08808
Bupranolol may decrease the bronchodilatory activities of Hexoprenaline.
DB13508
Cloranolol may decrease the bronchodilatory activities of Hexoprenaline.
DB13530
Mepindolol may decrease the bronchodilatory activities of Hexoprenaline.
DB13775
Tertatolol may decrease the bronchodilatory activities of Hexoprenaline.
DB00232
Hexoprenaline may increase the hypokalemic activities of Methyclothiazide.
DB00310
Hexoprenaline may increase the hypokalemic activities of Chlorthalidone.
DB00436
Hexoprenaline may increase the hypokalemic activities of Bendroflumethiazide.
DB00524
Hexoprenaline may increase the hypokalemic activities of Metolazone.
DB00562
Hexoprenaline may increase the hypokalemic activities of Benzthiazide.
DB00774
Hexoprenaline may increase the hypokalemic activities of Hydroflumethiazide.
DB00808
Hexoprenaline may increase the hypokalemic activities of Indapamide.
DB00880
Hexoprenaline may increase the hypokalemic activities of Chlorothiazide.
DB00999
Hexoprenaline may increase the hypokalemic activities of Hydrochlorothiazide.
DB01021
Hexoprenaline may increase the hypokalemic activities of Trichlormethiazide.
DB01324
Hexoprenaline may increase the hypokalemic activities of Polythiazide.
DB01325
Hexoprenaline may increase the hypokalemic activities of Quinethazone.
DB13532
Hexoprenaline may increase the hypokalemic activities of Cyclopenthiazide.
DB13989
Hexoprenaline may increase the hypokalemic activities of Epitizide.
DB00214
The risk or severity of hypokalemia can be increased when Hexoprenaline is combined with Torasemide.
DB00695
The risk or severity of hypokalemia can be increased when Hexoprenaline is combined with Furosemide.
DB00887
The risk or severity of hypokalemia can be increased when Hexoprenaline is combined with Bumetanide.
DB00903
The risk or severity of hypokalemia can be increased when Hexoprenaline is combined with Etacrynic acid.
DB02925
The risk or severity of hypokalemia can be increased when Hexoprenaline is combined with Piretanide.
DB08961
The risk or severity of hypokalemia can be increased when Hexoprenaline is combined with Azosemide.
DB00601
The risk or severity of adverse effects can be increased when Linezolid is combined with Hexoprenaline.
DB00614
The risk or severity of adverse effects can be increased when Furazolidone is combined with Hexoprenaline.
DB00721
The risk or severity of adverse effects can be increased when Procaine is combined with Hexoprenaline.
DB00752
The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Hexoprenaline.
DB00780
The risk or severity of adverse effects can be increased when Phenelzine is combined with Hexoprenaline.
DB00805
The risk or severity of adverse effects can be increased when Minaprine is combined with Hexoprenaline.
DB01037
The risk or severity of adverse effects can be increased when Selegiline is combined with Hexoprenaline.
DB01168
The risk or severity of adverse effects can be increased when Procarbazine is combined with Hexoprenaline.
DB01171
The risk or severity of adverse effects can be increased when Moclobemide is combined with Hexoprenaline.
DB01247
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Hexoprenaline.
DB01367
The risk or severity of adverse effects can be increased when Rasagiline is combined with Hexoprenaline.
DB01626
The risk or severity of adverse effects can be increased when Pargyline is combined with Hexoprenaline.
DB04017
The risk or severity of adverse effects can be increased when Clorgiline is combined with Hexoprenaline.
DB04818
The risk or severity of adverse effects can be increased when Iproniazid is combined with Hexoprenaline.
DB04820
The risk or severity of adverse effects can be increased when Nialamide is combined with Hexoprenaline.
DB06654
The risk or severity of adverse effects can be increased when Safinamide is combined with Hexoprenaline.
DB08550
The risk or severity of adverse effects can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Hexoprenaline.
DB09241
The risk or severity of adverse effects can be increased when Methylene blue is combined with Hexoprenaline.
DB09243
The risk or severity of adverse effects can be increased when Hydracarbazine is combined with Hexoprenaline.
DB09244
The risk or severity of adverse effects can be increased when Pirlindole is combined with Hexoprenaline.
DB09245
The risk or severity of adverse effects can be increased when Toloxatone is combined with Hexoprenaline.
DB09246
The risk or severity of adverse effects can be increased when Benmoxin is combined with Hexoprenaline.
DB09248
The risk or severity of adverse effects can be increased when Mebanazine is combined with Hexoprenaline.
DB09249
The risk or severity of adverse effects can be increased when Octamoxin is combined with Hexoprenaline.
DB09250
The risk or severity of adverse effects can be increased when Pheniprazine is combined with Hexoprenaline.
DB09251
The risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Hexoprenaline.
DB09252
The risk or severity of adverse effects can be increased when Pivhydrazine is combined with Hexoprenaline.
DB09253
The risk or severity of adverse effects can be increased when Safrazine is combined with Hexoprenaline.
DB09254
The risk or severity of adverse effects can be increased when Caroxazone is combined with Hexoprenaline.
DB13875
The risk or severity of adverse effects can be increased when Harmaline is combined with Hexoprenaline.
DB13876
The risk or severity of adverse effects can be increased when Brofaromine is combined with Hexoprenaline.
DB00221
The risk or severity of adverse effects can be increased when Isoetharine is combined with Hexoprenaline.
DB00368
The risk or severity of adverse effects can be increased when Norepinephrine is combined with Hexoprenaline.
DB00397
The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Hexoprenaline.
DB00668
The risk or severity of adverse effects can be increased when Epinephrine is combined with Hexoprenaline.
DB00816
The risk or severity of adverse effects can be increased when Orciprenaline is combined with Hexoprenaline.
DB00841
The risk or severity of adverse effects can be increased when Dobutamine is combined with Hexoprenaline.
DB00867
The risk or severity of adverse effects can be increased when Ritodrine is combined with Hexoprenaline.
DB00871
The risk or severity of adverse effects can be increased when Terbutaline is combined with Hexoprenaline.
DB00901
The risk or severity of adverse effects can be increased when Bitolterol is combined with Hexoprenaline.
DB00938
The risk or severity of adverse effects can be increased when Salmeterol is combined with Hexoprenaline.
DB01001
The risk or severity of adverse effects can be increased when Salbutamol is combined with Hexoprenaline.
DB01064
The risk or severity of adverse effects can be increased when Isoprenaline is combined with Hexoprenaline.
DB01102
The risk or severity of adverse effects can be increased when Arbutamine is combined with Hexoprenaline.
DB01274
The risk or severity of adverse effects can be increased when Arformoterol is combined with Hexoprenaline.
DB01288
The risk or severity of adverse effects can be increased when Fenoterol is combined with Hexoprenaline.
DB01291
The risk or severity of adverse effects can be increased when Pirbuterol is combined with Hexoprenaline.
DB01363
The risk or severity of adverse effects can be increased when Ephedra sinica root is combined with Hexoprenaline.
DB01366
The risk or severity of adverse effects can be increased when Procaterol is combined with Hexoprenaline.
DB01407
The risk or severity of adverse effects can be increased when Clenbuterol is combined with Hexoprenaline.
DB01408
The risk or severity of adverse effects can be increased when Bambuterol is combined with Hexoprenaline.
DB05039
The risk or severity of adverse effects can be increased when Indacaterol is combined with Hexoprenaline.
DB06262
The risk or severity of adverse effects can be increased when Droxidopa is combined with Hexoprenaline.
DB06814
The risk or severity of adverse effects can be increased when Protokylol is combined with Hexoprenaline.
DB09080
The risk or severity of adverse effects can be increased when Hexoprenaline is combined with Olodaterol.
DB09082
The risk or severity of adverse effects can be increased when Hexoprenaline is combined with Vilanterol.
DB11124
The risk or severity of adverse effects can be increased when Hexoprenaline is combined with Racepinephrine.
DB11587
The risk or severity of adverse effects can be increased when Hexoprenaline is combined with Etafedrine.
DB11871
The risk or severity of adverse effects can be increased when Hexoprenaline is combined with PF-00610355.
DB12100
The risk or severity of adverse effects can be increased when Hexoprenaline is combined with Abediterol.
DB12526
The risk or severity of adverse effects can be increased when Hexoprenaline is combined with Batefenterol.
DB13139
The risk or severity of adverse effects can be increased when Hexoprenaline is combined with Levosalbutamol.
DB09273
The risk or severity of adverse effects can be increased when Hexoprenaline is combined with Doxofylline.
DB00187
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Esmolol.
DB00195
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Betaxolol.
DB00264
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Metoprolol.
DB00335
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Atenolol.
DB00598
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Labetalol.
DB00612
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Bisoprolol.
DB01136
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Carvedilol.
DB01182
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Propafenone.
DB01193
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Acebutolol.
DB01295
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Bevantolol.
DB01297
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Practolol.
DB03322
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Dexpropranolol.
DB04846
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Celiprolol.
DB04861
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Nebivolol.
DB06726
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Bufuralol.
DB08952
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Indenolol.
DB09204
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Arotinolol.
DB09351
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Levobetaxolol.
DB11770
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Talinolol.
DB11785
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Anisodamine.
DB12752
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Bucindolol.
DB13443
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Esatenolol.
DB13757
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Epanolol.
DB12212
The therapeutic efficacy of Landiolol can be decreased when used in combination with Hexoprenaline.
DB00226
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Guanadrel.
DB00392
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Profenamine.
DB01158
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Bretylium.
DB01170
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Guanethidine.
DB12057
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with ORM-12741.
DB00184
The risk or severity of Tachycardia can be increased when Nicotine is combined with Hexoprenaline.
DB00193
The risk or severity of Tachycardia can be increased when Tramadol is combined with Hexoprenaline.
DB00209
The risk or severity of Tachycardia can be increased when Trospium is combined with Hexoprenaline.
DB00219
The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Hexoprenaline.
DB00245
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Hexoprenaline.
DB00261
The risk or severity of Tachycardia can be increased when Anagrelide is combined with Hexoprenaline.
DB00280
The risk or severity of Tachycardia can be increased when Disopyramide is combined with Hexoprenaline.
DB00332
The risk or severity of Tachycardia can be increased when Ipratropium is combined with Hexoprenaline.
DB00340
The risk or severity of Tachycardia can be increased when Metixene is combined with Hexoprenaline.
DB00354
The risk or severity of Tachycardia can be increased when Buclizine is combined with Hexoprenaline.
DB00366
The risk or severity of Tachycardia can be increased when Doxylamine is combined with Hexoprenaline.
DB00376
The risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Hexoprenaline.
DB00383
The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Hexoprenaline.
DB00387
The risk or severity of Tachycardia can be increased when Procyclidine is combined with Hexoprenaline.
DB00424
The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Hexoprenaline.
DB00434
The risk or severity of Tachycardia can be increased when Cyproheptadine is combined with Hexoprenaline.
DB00462
The risk or severity of Tachycardia can be increased when Methscopolamine bromide is combined with Hexoprenaline.
DB00470
The risk or severity of Tachycardia can be increased when Dronabinol is combined with Hexoprenaline.
DB00483
The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Hexoprenaline.
DB00486
The risk or severity of Tachycardia can be increased when Nabilone is combined with Hexoprenaline.
DB00496
The risk or severity of Tachycardia can be increased when Darifenacin is combined with Hexoprenaline.
DB00505
The risk or severity of Tachycardia can be increased when Tridihexethyl is combined with Hexoprenaline.
DB00508
The risk or severity of Tachycardia can be increased when Triflupromazine is combined with Hexoprenaline.
DB00517
The risk or severity of Tachycardia can be increased when Anisotropine methylbromide is combined with Hexoprenaline.
DB00555
The risk or severity of Tachycardia can be increased when Lamotrigine is combined with Hexoprenaline.
DB00640
The risk or severity of Tachycardia can be increased when Adenosine is combined with Hexoprenaline.
DB00670
The risk or severity of Tachycardia can be increased when Pirenzepine is combined with Hexoprenaline.
DB00697
The risk or severity of Tachycardia can be increased when Tizanidine is combined with Hexoprenaline.
DB00715
The risk or severity of Tachycardia can be increased when Paroxetine is combined with Hexoprenaline.
DB00725
The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Hexoprenaline.
DB00728
The risk or severity of Tachycardia can be increased when Rocuronium is combined with Hexoprenaline.
DB00747
The risk or severity of Tachycardia can be increased when Scopolamine is combined with Hexoprenaline.
DB00767
The risk or severity of Tachycardia can be increased when Benzquinamide is combined with Hexoprenaline.
DB00771
The risk or severity of Tachycardia can be increased when Clidinium is combined with Hexoprenaline.
DB00782
The risk or severity of Tachycardia can be increased when Propantheline is combined with Hexoprenaline.
DB00804
The risk or severity of Tachycardia can be increased when Dicyclomine is combined with Hexoprenaline.
DB00810
The risk or severity of Tachycardia can be increased when Biperiden is combined with Hexoprenaline.
DB00835
The risk or severity of Tachycardia can be increased when Brompheniramine is combined with Hexoprenaline.
DB00907
The risk or severity of Tachycardia can be increased when Cocaine is combined with Hexoprenaline.
DB00934
The risk or severity of Tachycardia can be increased when Maprotiline is combined with Hexoprenaline.
DB00940
The risk or severity of Tachycardia can be increased when Methantheline is combined with Hexoprenaline.
DB00942
The risk or severity of Tachycardia can be increased when Cycrimine is combined with Hexoprenaline.
DB00986
The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Hexoprenaline.
DB01036
The risk or severity of Tachycardia can be increased when Tolterodine is combined with Hexoprenaline.
DB01062
The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Hexoprenaline.
DB01069
The risk or severity of Tachycardia can be increased when Promethazine is combined with Hexoprenaline.
DB01075
The risk or severity of Tachycardia can be increased when Diphenhydramine is combined with Hexoprenaline.
DB01148
The risk or severity of Tachycardia can be increased when Flavoxate is combined with Hexoprenaline.
DB01166
The risk or severity of Tachycardia can be increased when Cilostazol is combined with Hexoprenaline.
DB01173
The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Hexoprenaline.
DB01221
The risk or severity of Tachycardia can be increased when Ketamine is combined with Hexoprenaline.
DB01226
The risk or severity of Tachycardia can be increased when Mivacurium is combined with Hexoprenaline.
DB01231
The risk or severity of Tachycardia can be increased when Diphenidol is combined with Hexoprenaline.
DB01239
The risk or severity of Tachycardia can be increased when Chlorprothixene is combined with Hexoprenaline.
DB01336
The risk or severity of Tachycardia can be increased when Metocurine is combined with Hexoprenaline.
DB01337
The risk or severity of Tachycardia can be increased when Pancuronium is combined with Hexoprenaline.
DB01338
The risk or severity of Tachycardia can be increased when Pipecuronium is combined with Hexoprenaline.
DB01409
The risk or severity of Tachycardia can be increased when Tiotropium is combined with Hexoprenaline.
DB01625
The risk or severity of Tachycardia can be increased when Isopropamide is combined with Hexoprenaline.
DB04834
The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Hexoprenaline.
DB04843
The risk or severity of Tachycardia can be increased when Mepenzolate is combined with Hexoprenaline.
DB05077
The risk or severity of Tachycardia can be increased when SLV319 is combined with Hexoprenaline.
DB06155
The risk or severity of Tachycardia can be increased when Rimonabant is combined with Hexoprenaline.
DB06702
The risk or severity of Tachycardia can be increased when Fesoterodine is combined with Hexoprenaline.
DB06787
The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Hexoprenaline.
DB08801
The risk or severity of Tachycardia can be increased when Dimetindene is combined with Hexoprenaline.
DB08897
The risk or severity of Tachycardia can be increased when Aclidinium is combined with Hexoprenaline.
DB08997
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Dexetimide.
DB09023
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Benactyzine.
DB09076
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Umeclidinium.
DB09089
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Trimebutine.
DB09262
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Imidafenacin.
DB09300
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Butylscopolamine.
DB11235
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Thonzylamine.
DB11315
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Methscopolamine.
DB11903
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with GW842166.
DB12086
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Oxitropium.
DB12193
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Ajulemic acid.
DB12554
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Mebeverine.
DB12649
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Ibipinabant.
DB13070
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Surinabant.
DB13252
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Tropatepine.
DB13254
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Prifinium.
DB13351
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Piperidolate.
DB13369
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Benzilone.
DB13380
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Difemerine.
DB13413
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Phenglutarimide.
DB13448
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Mazaticol.
DB13468
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Etybenzatropine.
DB13500
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Otilonium.
DB13505
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Emepronium.
DB13507
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Poldine.
DB13542
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Bevonium.
DB13581
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Rociverine.
DB13619
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Bornaprine.
DB13636
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Etanautine.
DB13666
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Tiemonium iodide.
DB13678
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Dihexyverine.
DB13695
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Penthienate.
DB13720
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Diphemanil.
DB13738
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Camylofin.
DB13759
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Fenpiverinium.
DB13769
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Emetonium iodide.
DB13844
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Pipenzolate.
DB13850
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Timepidium.
DB13950
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with WIN 55212-2.
DB14009
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Medical Cannabis.
DB14011
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Nabiximols.
DB14043
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Palmidrol.
DB09007
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Chlorphenoxamine.
DB11823
The risk or severity of hypertension can be increased when Esketamine is combined with Hexoprenaline.
DB14754
The risk or severity of hypertension can be increased when Solriamfetol is combined with Hexoprenaline.
DB13946
Testosterone undecanoate may increase the hypertensive activities of Hexoprenaline.
DB00983
Formoterol may increase the sympathomimetic activities of Hexoprenaline.
DB14513
The serum concentration of Magnesium can be decreased when it is combined with Hexoprenaline.

序列

实验性质

Melting Point
222-228
U.S. Patent 3,329,709.

外部标识符

resource：PubChem Compound
identifier：3609
resource：PubChem Substance
identifier：310264922
resource：ChemSpider
identifier：3483
resource：BindingDB
identifier：50239967
resource：Wikipedia
identifier：Hexoprenaline
resource：ChEMBL
identifier：CHEMBL1589896
resource：RxCUI
identifier：5307

外部链接

Drugs.com
http://www.drugs.com/international/hexoprenaline.html

路径

目标

酶

载体

运输工具

药物反应

效应

不良反应